Treatment Updates
  • Featured content
    In this CME-certified module with downloadable slides, William Tap, MD, reviews clinical data surrounding the use of established and novel approved agents and emerging investigational therapeutics for treating advanced soft tissue sarcoma.
  • Featured content
    Review these downloadable slides to gain expert perspective and current guideline recommendations for using immune checkpoint inhibitors for patients with urothelial cell or renal cell carcinoma. Faculty, Elizabeth R. Plimack, MD, MS; Timothy M. Kuzel, MD, FACP; and M. Dror Michaelson, MD, PhD, explain the current clinical rational and use of various immunotherapy options for both bladder and kidney cancer.
  • Featured content
    Manish A. Shah, MD, reviews the central role of cancer stem cells in GI cancer tumorigenesis, relapse, and metastasis and assesses emerging clinical data for novel cancer stem cell–targeted therapies in the treatment of patients with gastric, colorectal, and pancreatic cancers.
  • Featured content
    This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms, particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other, including an Interactive Treatment Decision Support Tool, an expert-authored commentary and module, and a downloadable slideset.
  • Featured content
    This comprehensive program gathers insight from 5 experts to discuss optimal management of patients with RCC, featuring education on new agents and enhanced by practical tools for applying these findings in the clinic. All aspects of this program are designed to complement each other, including an interactive treatment decision aid, expert commentaries, and an expert-authored CME/CE-certified module with downloadable slideset.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Programs

10 of 291 Shown
10 of 291 Shown
Show 10 More
Loading...